In the present study, we conducted a single center retrospective analysis evaluating the prognostic role of Olig2 as well as other glioma stem cell and oligodendroglial markers in a glioblastoma cohort using a multivariate analysis including established clinical and molecular prognostic markers. This evidence concerns the gene OLIG2 and central nervous system cancer.